【摘要】：目的:應(yīng)用博來(lái)霉素(bleomycin,BLM)誘導(dǎo)大鼠構(gòu)建肺纖維化模型,探討基質(zhì)金屬蛋白酶-9(matrix metalloproteinase-9,MMP-9)、基質(zhì)金屬蛋白酶抑制劑-1(tissue inhibitor of metalloproteinase-1,TIMP-1)在肺纖維化過(guò)程中的表達(dá)及應(yīng)用外源性硫化氫的干預(yù)作用。方法:健康雄性SD大鼠共45只,按隨機(jī)數(shù)字表法分為3組(每組15只),即對(duì)照組、BLM組、BLM+Na HS(硫化氫供體)組。BLM組、BLM+Na HS組按5mg/kg劑量給予BLM溶液一次性氣管內(nèi)注入建立肺纖維化模型,對(duì)照組氣管內(nèi)注入等體積的生理鹽水,造模后第一天開(kāi)始,BLM+Na HS組每天腹腔注射N(xiāo)a HS溶液(28μmol/kg);BLM組和對(duì)照組每天腹腔注射等體積生理鹽水。造模后分別在第7,14,28天進(jìn)行取材,各組每次隨機(jī)處死5只大鼠。取左肺組織放于4%甲醛固定后做HE染色和Masson染色電鏡觀察肺泡炎和肺纖維化改變,免疫組織化學(xué)染色法檢測(cè)肺組織中MMP-9、TIMP-1蛋白的表達(dá)情況;取右肺組織進(jìn)行RT-PCR檢測(cè)肺組織中MMP-9、TIMP-1 m RNA的表達(dá)情況。結(jié)果:1.HE和Masson染色結(jié)果顯示:對(duì)照組各時(shí)間段均未見(jiàn)炎癥及肺纖維化改變,BLM組7d以炎癥反應(yīng)為主,14d開(kāi)始出現(xiàn)纖維區(qū),肺泡腔開(kāi)始出現(xiàn)較多肺成纖維細(xì)胞;28d肺泡炎癥明顯減輕,肺泡腔內(nèi)可見(jiàn)大量肌成纖維細(xì)胞及膠原沉積,肺纖維化模型形成;BLM+Na HS組也出現(xiàn)了肺泡炎和纖維化改變,但較BLM組有明顯減輕。2.免疫組化和RT-PCR結(jié)果顯示:對(duì)照組各時(shí)期MMP-9、TIMP-1僅有少量表達(dá),而B(niǎo)LM組和BLM+Na HS組MMP-9、TIMP-1表達(dá)與對(duì)照組比較有顯著增加,差異有統(tǒng)計(jì)學(xué)意義(P㩳0.05),BLM+Na HS處理組MMP-9的表達(dá)在各時(shí)間階段較BLM組有不同程度減低,7d時(shí)MMP-9表達(dá)降低與BLM組比較差異有顯著統(tǒng)計(jì)學(xué)意義(P㩳0.01),14、28d較BLM組比較差異有統(tǒng)計(jì)學(xué)意義(P㩳0.05),BLM+Na HS組TIMP-1的表達(dá)在各時(shí)間階段較BLM組有不同程度的降低,7d時(shí)差異有統(tǒng)計(jì)學(xué)意義(P㩳0.05),14、28d時(shí)差異有顯著統(tǒng)計(jì)學(xué)意義(P㩳0.01)。3.MMP-9/TIMP-1平衡比值結(jié)果顯示:與對(duì)照組比較,BLM組MMP-9/TIMP-1平衡比值在7d時(shí)較對(duì)照組升高,差異有顯著統(tǒng)計(jì)學(xué)意義(P㩳0.01),在14、28d時(shí)比值較對(duì)照組降低,差異有統(tǒng)計(jì)學(xué)意義(P㩳0.05);BLM+Na HS組MMP-9/TIMP-1比值在7d時(shí)較BLM組下降,差異有統(tǒng)計(jì)學(xué)意義(P㩳0.05),14、28d較BLM組有升高,差異有統(tǒng)計(jì)學(xué)意義(P㩳0.05);較對(duì)照組比較,BLM+Na HS組MMP-9/TIMP-1比值在7d時(shí)有升高,差異有統(tǒng)計(jì)學(xué)意義(P㩳0.05),14、28d時(shí)比值有降低,差異無(wú)統(tǒng)計(jì)學(xué)意義。結(jié)論:1.外源性硫化氫能夠減輕博來(lái)霉素所致大鼠肺泡炎和肺纖維化的程度,具有抗肺纖維化作用。2.外源性硫化氫抗肺纖維化機(jī)制之一可能是抑制肺組織中MMP-9、TIMP-1的表達(dá),并在一定程度上調(diào)整MMP-9和TIMP-1的比值使其趨于平衡。
[Abstract]:Aim: to investigate the expression of matrix metalloproteinase-9 (matrix metalloproteinase-9) and matrix metalloproteinase-1 (TIMP-1) in pulmonary fibrosis induced by bleomycin (BLM) and the effects of exogenous hydrogen sulfide (H2S) on the expression of matrix metalloproteinase-1 (TIMP-1) in pulmonary fibrosis. Methods: there were 45 healthy male SD rats. According to the random number table method, the rats were divided into three groups (15 rats in each group), namely, the control group was treated with BLM Na HS (hydrogen sulfide donor. The model of pulmonary fibrosis was established by intratracheal instillation of BLM solution in the BLM Na HS group according to the dose of 5mg/kg. The same volume of saline was injected into the trachea of the control group. The same volume of saline was injected intraperitoneally every day in the BLM Na HS group (28 渭 mol/kg) and the control group on the first day after the establishment of the model. After modeling, 5 rats were randomly killed in each group on day 14, 28, respectively. The changes of alveolitis and pulmonary fibrosis were observed by HE staining and Masson staining after the left lung tissue was fixed with 4% formaldehyde. The expression of MMP-9 and TIMP-1 protein was detected by immunohistochemical staining. The expression of MMP-9 and TIMP-1 m RNA was detected by RT-PCR in right lung tissue. Results 1. The results of HE and Masson staining showed that there were no inflammatory and pulmonary fibrosis changes in the control group. In the BLM group, the inflammatory reaction mainly appeared on the 14th day, and the alveolar inflammation began to appear in the alveolar cavity. The alveolar inflammation in the alveolar cavity began to appear more than 28 days, and the alveolar inflammation was obviously alleviated. A large number of myofibroblasts and collagen deposition could be seen in the alveolar cavity, and alveolitis and fibrosis were also found in the model of pulmonary fibrosis in the BLM Na HS group, but the changes of alveolitis and fibrosis were significantly reduced compared with those in the BLM group. The results of immunohistochemistry and RT-PCR showed that there was only a little expression of MMP-9 and TIMP-1 in the control group, while the expression of MMP-9 and TIMP-1 in the BLM group and BLM Na HS group was significantly higher than that in the control group. The expression of MMP-9 in BLM-Na HS group was significantly lower than that in BLM group at 7 days after treatment with BLM Na HS. There was significant difference between BLM group and BLM group (P0. 01) 1428 days after treatment, there was significant difference between BLM group and BLM group. (P0. 05) the expression of TIMP-1 in BLMNa HS group was significantly lower than that in BLM group at day 7 (P0. 05). (P0. 01). The results of MMP-9 / TIMP-1 balance ratio showed that: compared with the control group, the MMP-9/TIMP-1 balance ratio of BLM group was significantly lower than that of control group (P0. 05). On the 7th day, it was higher than that of the control group. The difference was statistically significant (P0. 01). The ratio of MMP-9/TIMP-1 in BLM Na HS group was significantly lower than that in BLM group at day 14 and 28. The ratio of MMP-9/TIMP-1 in BLM Na HS group was significantly lower than that in BLM group at day 7, and the difference was statistically significant (P0. 05) at 1428 days, which was higher than that in BLM group. Compared with the control group, the ratio of MMP-9/TIMP-1 increased at the 7th day, and decreased at 14 ~ 28 days, but there was no significant difference in the ratio between the two groups (P < 0. 05, P < 0. 05), but no significant difference was found between the control group and the control group (P < 0. 05, P < 0. 05). Conclusion 1. Exogenous hydrogen sulfide can reduce the degree of alveolitis and pulmonary fibrosis induced by bleomycin in rats. One of the mechanisms of exogenous hydrogen sulfide against pulmonary fibrosis may be to inhibit the expression of MMP-9 and TIMP-1 in lung tissues and to adjust the ratio of MMP-9 and TIMP-1 to a certain extent to balance them.
【學(xué)位授予單位】：南華大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類(lèi)號(hào)】：R563

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 ;Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis[J];World Journal of Gastroenterology;2004年01期

2 陰峧宏,馬紅,馬雪梅,朱躍科,賈繼東,王寶恩;膽管阻塞性大鼠肝纖維化模型肝組織TIMP1mRNA表達(dá)及復(fù)方861抑制作用的研究[J];中醫(yī)藥通報(bào);2002年02期

3 ;SIGNIFICANCE OF MMP-2 AND TIMP-2 mRNA EXPRESSIONS ON GLOMERULAR CELLS IN THE DEVELOPMENT OF GLOMERULOSCLEROSIS[J];Chinese Medical Sciences Journal;2004年02期

4 ;Expression of TIMP-3 Gene by Construction of a Eukaryotic Cell Expression Vector and Its Role in Reduction of Metastasis in a Human Breast Cancer Cell Line[J];Cellular & Molecular Immunology;2004年04期

5 Alvin K.H.Kwok,Timothy Y.Y.Lai,Hin-Fai Yam,Chi-Pui Pang;TIMP-1 Production in Human Retinal Pigment Epithelial Cells after Laser Exposure[J];眼科學(xué)報(bào);2005年01期

6 唐琳;劉章鎖;張?jiān)茲h;高冬玲;;TIMP-1綠色熒光蛋白真核表達(dá)載體的構(gòu)建和鑒定[J];鄭州大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2006年03期

7 曾愛(ài)萍;曾水清;程揚(yáng);肖青;;Modulation of Matrix Metalloproteinase and TIMP-1 Expression by TGF-β_1 in Cultured Human RPE Cells[J];華中科技大學(xué)學(xué)報(bào)(醫(yī)學(xué)英德文版);2006年03期

8 SeakwooLee;KevinKDesai;Kenneth A Iczkowski;Robert G Newcomer;Kevin J Wu;Winston W Tan;MarkDRoycik;Qing-XiangAmySang;;Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor[J];Cell Research;2006年09期

9 滕紅林;魏海峰;吳春雷;林利興;陳雷;楊勝武;;TIMP-4基因的克隆、原核表達(dá)及活性測(cè)定[J];溫州醫(yī)學(xué)院學(xué)報(bào);2008年01期

10 孟赤;陳旭娥;李家文;吳艷;劉厚君;;Expression of MMP-9 and TIMP-1 in Lesions of Systemic Sclerosis and Its Implications[J];Journal of Huazhong University of Science and Technology(Medical Sciences);2008年04期

相關(guān)會(huì)議論文 前10條

1 ;Study of TIMP-2 Gene Over-expression Inhibiting the Invasiveness of Ameloblastoma cells in vitro[A];中華口腔醫(yī)學(xué)會(huì)老年口腔醫(yī)學(xué)專(zhuān)業(yè)委員會(huì)換屆選舉暨第四屆全國(guó)老年口腔醫(yī)學(xué)學(xué)術(shù)研討會(huì)論文匯編[C];2008年

2 梁清華;湯天鳳;羅徐;;痹腫消湯對(duì)活動(dòng)期RA患者血清MMP-3及TIMP-1的影響[A];全國(guó)中西醫(yī)結(jié)合強(qiáng)直性脊柱炎專(zhuān)題研討會(huì)論文匯編[C];2007年

3 yuejie yang;;Effect of IL-10 on expression of CTGF、TIMP-1 in Hepatic Stellate Cells mediated by TGFβ1[A];中華醫(yī)學(xué)會(huì)第十六次全國(guó)病毒性肝炎及肝病學(xué)術(shù)會(huì)議論文匯編[C];2013年

4 ;Study of TIMP-2 Gene Over-expression Inhibiting the Invasiveness of Ameloblastoma Xenografts on CAM[A];中華口腔醫(yī)學(xué)會(huì)老年口腔醫(yī)學(xué)專(zhuān)業(yè)委員會(huì)換屆選舉暨第四屆全國(guó)老年口腔醫(yī)學(xué)學(xué)術(shù)研討會(huì)論文匯編[C];2008年

5 盧曉梅;陳琦;溫浩;鄭莉;任加強(qiáng);朱虹光;;金屬蛋白酶組織抑制劑1(TIMP-1)的克隆與序列分析[A];第七屆全國(guó)腫瘤生物治療學(xué)術(shù)會(huì)議論文集[C];2001年

6 王虹;曾位森;陳金華;鄒耀東;劉丹;楊艷妮;;組織金屬蛋白抑制因子-1(TIMP-1)單克隆抗體的制備及ELISA檢測(cè)試劑盒的研制[A];第6次全國(guó)微生物學(xué)與免疫學(xué)大會(huì)論文摘要匯編[C];2004年

7 薛博瑜;李q詮，

本文編號(hào)：2182853